[email protected]

01252 375362

01252 375362

  • About Us
    • About Pharmacy Consulting
    • Our Team
    • Work with us
    • Testimonials
  • Consultancy
    • For Pharmaceutical Wholesalers
    • For Pharmacies
    • Care Quality Commission – CQC
    • Pharmaceutical Manufacturers
    • Medical Devices Consultancy and Training
  • Flexible Training
    • Good Distribution Practice (GDP) Training
    • RPi Training
    • Licence Holder Training
    • Export Training
    • Audit Training
    • Active Pharmaceutical Ingredient (API) and Clinical Trials Training
    • Superintendent Pharmacist Training
    • GPhC Guidance for Online Pharmacies
  • RP Cogent GDP Training
  • RP Forum
  • Training Calendar
  • Our CPD
    • Blog
    • Editorial Items
    • Social Media
  • Contact Us
Inclisiran to save the lives of thousands of NHS Patients

Inclisiran to save the lives of thousands of NHS Patients

by Amelia Holmes | Oct 8, 2021 | Blog

Inclisiran – A Cholesterol lowering Injection has been made available to save the lives of thousands of NHS Patients. Thanks to a world-leading NHS ‘Population Health Agreement’ between the NICE, the NHS and Novartis for Inclisiran

ILAP – Innovative Licensing and Access Pathway

ILAP – Innovative Licensing and Access Pathway

by Amelia Holmes | Oct 5, 2021 | Blog

ILAP – Following agreement by Welsh Ministers the All Wales Therapeutics and Toxicology Centre (AWTTC) will have joined established partners of the Innovative Licensing and Access Pathway (ILAP) as of Monday 4th of October 2021.

Ronapreve, in the fight against Covid-19

Ronapreve, in the fight against Covid-19

by Amelia Holmes | Sep 27, 2021 | Blog, Covid 19, MHRA

Ronapreve, the next lifesaving drug in the fight against Covid-19. Following a recommendation by the Commission on Human Medicines (CHM)

The Future of Medical Device Regulation

The Future of Medical Device Regulation

by Amelia Holmes | Sep 27, 2021 | Blog, Medical Devices, MHRA, Regulation

The Future of Medical Device Regulation, on the 16th of September, the Medicines and Healthcare products Regulatory Agency (MHRA) launched a 10- week

Next Entries »

Recent Posts

  • Communication from the GPhC regarding Regulatory Concerns
  • Professional Indemnity Insurance
  • FDA Warning Letters

Upcoming Courses

  • Introduction to Good Distribution Practice Online Training on 10 September 2025 10:00 am
  • GDP/RP Cogent Gold Standard Online Training on 16 September 2025
  • GDP Audit Online Training on 1 October 2025 10:00 am
  • Licence Holder Training on 14 October 2025 10:00 am
  • GDP/RP Cogent Gold Standard Online Training on 21 October 2025

MHRA Alerts & Recalls

Field Safety Notices: 1 to 5 September 2025
9 September 2025
Class 4 Medicines Defect Notification: Hikma Farmacêutica, Gemcitabine 2g/52.6ml concentrate for solution for infusion, EL(25)A/43
4 September 2025
Profemur Cobalt Chrome Modular Neck Hip Replacements: Higher than anticipated risk of revision surgery, metal-wear effects and component fracture (DSI/2025/005)
4 September 2025
Field Safety Notices: 25 to 29 August 2025
3 September 2025

Get In Touch

Address:
Wellesley House
10 Eelmoor Road
Farnborough
Hampshire
GU14 7QN

Phone: 01252 375362
Email: [email protected]
  • Terms and Conditions
  • Privacy Policy

Designed by Four Lakes

  • Follow
  • Follow
  • Follow
  • Follow